Live Breaking News & Updates on Sanofi Incyte

Stay updated with breaking news from Sanofi incyte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company… ....

Rhui Zhou , United States , Hong Kong , Sanofi Incyte , Eli Lilly , Wei Li , Innovent Biologics , Caicun Zhou , China National Medical Products Administration , Md Anderson Cancer Center , Drug Administration , National Medical Products Administration , Innovent Or Company , Department Of Oncology At Shanghai East Hospital , Tongji University , Innovent Biologics Inc , American Society Of Clinical Oncology , Clinical Oncology , Drug Evaluation , Principal Investigator , Shanghai East Hospital , Senior Vice President , Breakthrough Therapy Designations , Priority Review Designations , New Drug Applications , Anheart Therapeutics ,

Innovent Announces Data From Pivotal Phase 2 TRUST-I Study Of Taletrectinib(ROS1 Inhibitor) Are Published In The JCO And Reported At 2024 ASCO Annual ...

SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 /PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceut ....

Rhui Zhou , Hong Kong , United States , Eli Lilly , Innovent Biologics , Caicun Zhou , Sanofi Incyte , Wei Li , Drug Administration , National Medical Products Administration , Department Of Oncology At Shanghai East Hospital , Innovent Or Company , Tongji University , China National Medical Products Administration , Md Anderson Cancer Center , American Society Of Clinical Oncology , Prnewswire Innovent Biologics Inc , Innovent Biologics Inc , Clinical Oncology , Drug Evaluation , Principal Investigator , Shanghai East Hospital , Senior Vice President , Breakthrough Therapy Designations , Priority Review Designations , New Drug Applications ,

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes. ....

Yu Chen , Rhui Zhou , United States , Innovent Biologics , Tingbo Liang , Sanofi Incyte , Eli Lilly , Prnewswire Innovent Biologics Inc , Zhejiang University , School Of Medicine , European Society For Medical Oncology , Md Anderson Cancer Center , European Society , Medical Oncology , Virtual Plenary , Senior Vice President , Colorectal Cancer , Fujian Cancer Hospital , First Affiliated Hospital ,

Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes. ....

Rhui Zhou , United States , Innovent Biologics , Hana Claudin , Eli Lilly , Xianjun Yu , Sanofi Incyte , Innovent Or Company , National Medical Products Administration , American Society Of Clinical Oncology , Gastrointestinal Cancers Congress , Innovent Biologics Inc , Fudan University Shanghai Cancer Center , Prnewswire Innovent Biologics Inc , Biliary Cancer Working Group , Md Anderson Cancer Center , Clinical Oncology , Annual Meeting , Cancers Congress , Senior Vice President , Biliary Cancer Working ,

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as Monotherapy for Advanced Gastric Cancer

SAN FRANCISCO and SUZHOU, China, May 7, 2024 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ....

United States , Rhui Zhou , Hong Kong , Sanofi Incyte , Eli Lilly , Innovent Biologics Inc , Md Anderson Cancer Center , China National Medical Products Administration , Incyte Corporation , Innovent Biologics , Drug Evaluation , National Medical Products Administration , Breakthrough Therapy Designation , Senior Vice President , Therapy Designation , Mainland China , Adv Med , Thailand Business ,